Evidence map›Paper›PMID 34261550›Full record

ArticleJournal of the International Neuropsychological Society : JINS2021

Daily Cannabis Use is Associated With Lower CNS Inflammation in People With HIV.

C Wei-Ming Watson, Laura M Campbell, Ni Sun-Suslow, Suzi Hong, Anya Umlauf, Ronald J Ellis, Jennifer E Iudicello, Scott Letendre, Thomas D Marcotte, Robert K Heaton and 2 more

Open access · greenAbstract read
In one paragraph

Article in Journal of the International Neuropsychological Society : JINS, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 3 pooled it
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 3 syntheses or guidelines pooled it, 47 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. ΔJournal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2026
    Article
  8. Neuroimmune Correlates of HIV and Marijuana Use: Peripheral Biomarkers and Cognitive Function.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

C Wei-Ming WatsonDepartment of Psychiatry, University of California, San Diego, USA.ORCID 0000-0001-7734-1469
Laura M CampbellDepartment of Psychiatry, University of California, San Diego, USA.ORCID 0000-0001-9790-1603
Ni Sun-SuslowDepartment of Psychiatry, University of California, San Diego, USA.
Suzi HongDepartment of Psychiatry, University of California, San Diego, USA.
Anya UmlaufDepartment of Psychiatry, University of California, San Diego, USA.
Ronald J EllisDepartment of Psychiatry, University of California, San Diego, USA.
Jennifer E IudicelloDepartment of Psychiatry, University of California, San Diego, USA.
Scott LetendreDepartment of Medicine, University of California, San Diego, USA.
Thomas D MarcotteDepartment of Psychiatry, University of California, San Diego, USA.
Robert K HeatonDepartment of Psychiatry, University of California, San Diego, USA.
Erin E MorganDepartment of Psychiatry, University of California, San Diego, USA.
Igor GrantDepartment of Psychiatry, University of California, San Diego, USA.
University of California San Diego · USSan Diego State University · US

Funding

STRUCTURAL NEUROIMAGING COREP30MH062512 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DAVID J MOORE · 2001 to 2026
$50.4M
Translational Methamphetamine AIDS Research Center (TMARC)P50DA026306 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GRANT, IGOR · 2009 to 2018
$33.9M
NEUROMOTORP01DA012065 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GRANT, IGOR · 1999 to 2009
$17.8M
Age related determinants of HAND: A 12 year follow-up of CHARTER participantsR01MH107345 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI HEATON, ROBERT KERNACHAN, LETENDRE, SCOTT L · 2015 to 2021
$7.9M
Training in Research on Addictions in Interdisciplinary NeuroAIDS (TRAIN)T32DA031098 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Jennifer E Iudicello, DAVID J MOORE · 2011 to 2026
$4.6M
Phase II trial of tesamorelin for cognition in aging HIV-infected personsR01AG048650 · NIA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DUBE, MICHAEL PHILLIP, ELLIS, RONALD J. · 2015 to 2020
$4.0M
Identification of Biomarkers of CNS injury and resilience related to HIV-1 and MethamphetamineR01DA047879 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI IUDICELLO, JENNIFER E, LETENDRE, SCOTT L · 2018 to 2022
$3.7M
Cannabis, inflammation, and the brain in persons with HIVR01DA053052 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI IUDICELLO, JENNIFER E · 2020 to 2024
$3.2M
Biomarkers of Blood Brain Barrier Injury in Methamphetamine Use and HIV DiseaseK23DA037793 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI IUDICELLO, JENNIFER E · 2014 to 2018
$915k
Multisystem risk profile of older adults to predict cognitive function and impairmentR03AG063328 · NIA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI HONG, SUZI · 2019 to 2021
$472k
CNS HIV ANTI-RETROVIRAL THERAPY EFFECTS RESEARCH /CHARTER/ -278022005-278022005N01MH022005 · NIMH · UNIVERSITY OF CA -SAN DIEGO · PI GRANT, IGOR · 2003 to 2006
–
NIA NIH HHS R01 AG048650NIA NIH HHS R03 AG063328NIDA NIH HHS K23 DA037793NIDA NIH HHS P01 DA012065NIDA NIH HHS P50 DA026306NIDA NIH HHS R01 DA047879NIDA NIH HHS R01 DA053052NIDA NIH HHS T32 DA031098NIMH NIH HHS HHSN271201000030CNIMH NIH HHS HHSN271201000036CNIMH NIH HHS N01 MH022005NIMH NIH HHS P30 MH062512NIMH NIH HHS R01 MH107345
6 · The paper itself

Abstract

objectiveRecent cannabis exposure has been associated with lower rates of neurocognitive impairment in people with HIV (PWH). Cannabis's anti-inflammatory properties may underlie this relationship by reducing chronic neuroinflammation in PWH. This study examined relations between cannabis use and inflammatory biomarkers in cerebrospinal fluid (CSF) and plasma, and cognitive correlates of these biomarkers within a community-based sample of PWH.

methods263 individuals were categorized into four groups: HIV- non-cannabis users (n = 65), HIV+ non-cannabis users (n = 105), HIV+ moderate cannabis users (n = 62), and HIV+ daily cannabis users (n = 31). Differences in pro-inflammatory biomarkers (IL-6, MCP-1/CCL2, IP-10/CXCL10, sCD14, sTNFR-II, TNF-α) by study group were determined by Kruskal-Wallis tests. Multivariable linear regressions examined relationships between biomarkers and seven cognitive domains, adjusting for age, sex/gender, race, education, and current CD4 count.

resultsHIV+ daily cannabis users showed lower MCP-1 and IP-10 levels in CSF compared to HIV+ non-cannabis users (p = .015; p = .039) and were similar to HIV- non-cannabis users. Plasma biomarkers showed no differences by cannabis use. Among PWH, lower CSF MCP-1 and lower CSF IP-10 were associated with better learning performance (all ps < .05).

conclusionsCurrent daily cannabis use was associated with lower levels of pro-inflammatory chemokines implicated in HIV pathogenesis and these chemokines were linked to the cognitive domain of learning which is commonly impaired in PWH. Cannabinoid-related reductions of MCP-1 and IP-10, if confirmed, suggest a role for medicinal cannabis in the mitigation of persistent inflammation and cognitive impacts of HIV.

Indexed as

CannabisHIV InfectionsBiomarkersCognitionHumansInflammationBiomarkerscannabinoidscerebrospinal fluidcognitionHIV/AIDSmarijuanaNeuroAIDSneurocognitive impairmentNeuroinflammation

Identifiers

PMID34261550
PMCPMC8288448
OpenAlexW3181330283

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.